Upon admission, we observed significantly lower ACE activities in COVID-19 patients compared with non-COVID-19 controls, while ACE2 activities and AngII and Ang1-7 concentrations did not differ between the two groups (Figure 2A). This evidence concerns the gene ACE2 and COVID-19.